ABBV vs TECH
By Alex · Tickerpine
AbbVie Inc. vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | TECH |
|---|---|---|
| Price | $295.03 | $72.80 |
| Market cap | $521.50B | $11.44B |
| P/E ratio | 50.7 | 66.8 |
| ROE | — | 8.33% |
| Profit margin | 15.67% | 14.00% |
| Revenue growth | 10.30% | 4.60% |
| Dividend yield | 2.35% | 0.44% |
| Beta | 0.19 | 1.27 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs TECH in plain English
- ABBV is the bigger company — about 45.6× the market cap of TECH.
- ABBV is cheaper on earnings (P/E 50.7 vs 66.8).
- ABBV is growing revenue faster (10% vs 5%).
- ABBV has the higher dividend yield (2.35% vs 0.44%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.